LEO

Comsat Architects and Ubotica Technologies Join Forces to Bring AI to Space

Retrieved on: 
Tuesday, March 12, 2024

Together, Comsat Architects and Ubotica will integrate Artificial Intelligence (AI) technologies into the combination of communication and Earth observation on small satellites in low Earth orbits to unlock the opportunity for Live Earth Intelligence.

Key Points: 
  • Together, Comsat Architects and Ubotica will integrate Artificial Intelligence (AI) technologies into the combination of communication and Earth observation on small satellites in low Earth orbits to unlock the opportunity for Live Earth Intelligence.
  • Comsat Architects provides services in space communication analysis, advanced software, and aerospace technologies to civil and commercial sectors.
  • Comsat Architects specializes in space connectivity for spacecraft in LEO orbit, and the infusion of AI/ML technologies into various aspects of data delivery.
  • "This strategic collaboration signifies a major milestone in harnessing the combined expertise of Comsat Architects and Ubotica to advance AI technologies in space systems," said Kul Bhasin, Ph.D., CEO of Comsat Architects.

As the skies become crowded with satellites and space junk, will it affect viewing the solar eclipse?

Retrieved on: 
Friday, April 5, 2024

On April 8, millions of people across Mexico, the United States and Canada will have the chance to see a total solar eclipse.

Key Points: 
  • On April 8, millions of people across Mexico, the United States and Canada will have the chance to see a total solar eclipse.
  • There is enormous public interest in viewing the eclipse: revenue from tourism is expected to top US$1 billion, comparable to the Super Bowl.

Bright satellites in the night sky

  • Currently, there are over 9,500 functional satellites in orbit, fully 60 per cent of which are Starlink satellites launched in the past five years.
  • These 5,700 Starlink satellites are bright and most are visible to the naked eye anytime they are sunlit and high in an observer’s night sky.

How bright are satellites during a total eclipse?

  • The brightness of satellites during the eclipse depends most strongly on how close the satellites are to observers on the ground.
  • In our simulation, we found that all satellites visible in the sky during the eclipse are inside the moon’s shadow, making them fainter than they would be otherwise.


When all these effects are taken into account, we predict the brightest satellites would be visible to the naked eye from a fully dark location. But during an eclipse, the sky is not very dark — it is even brighter than the night sky during a full moon, making only the brightest stars visible. For this reason, we do not expect these satellites to be visible as “moving stars”.

Satellite glints are becoming more common

  • Glints are short, bright reflections from large, flat surfaces on satellites and tumbling, abandoned rocket bodies.
  • Our brightness model uses a simple sphere for predicting satellite brightnesses, which does a reasonable job of reproducing the overall brightness distribution, but does not include glints.
  • Predicting glints requires knowing the exact shape and orientation of each satellite, which most megaconstellation operators consider proprietary and do not share with anyone outside their corporations.

Documenting the eclipse

  • If you think you saw some satellites, either as a moving star or as a short glint, let us know.
  • A timer would be ideal, so you can let the camera record the sky while you focus on enjoying the eclipse.
  • Read more:
    Photographing the eclipse?

Satellites are changing the sky, worldwide

  • Satellites are changing every aspect of stargazing and astronomy research, as well as polluting the atmosphere and threatening the future use of Earth orbits.
  • If you are fortunate to be along the path of the April 2024 eclipse, go out and enjoy it.


Samantha Lawler receives funding from the Natural Sciences and Engineering Research Council of Canada (NSERC). Aaron Boley receives Canadian tri-agency funding and is a Canada Research Chair in planetary astronomy. He is the co-director of the Outer Space Institute. Hanno Rein receives funding from the Natural Sciences and Engineering Research Council of Canada (NSERC).

Coastal Carolina University launches South Carolina’s first space satellite program

Retrieved on: 
Wednesday, February 28, 2024

Conway, S.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Coastal Carolina University announces the launch of the CCU Space Program, the first such endeavor in South Carolina.

Key Points: 
  • Conway, S.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Coastal Carolina University announces the launch of the CCU Space Program, the first such endeavor in South Carolina.
  • The CCU Space Program will allow students to develop strong job-transferrable skills and may inspire the next generation of explorers.”
    Through this program, space technology will be levered to conduct scientific research aimed at addressing pressing issues in the management of the coastal environment and focus on monitoring and managing coastal erosion, sea-level rise, stormwater runoff, and other ecological concerns critical to the health of South Carolina’s coastal regions.
  • The CCU Space Program will offer an innovative and educational experience for students in intelligence and security studies.
  • In addition, the program will play a crucial role in safeguarding and managing cultural heritage assets, thus preserving South Carolina’s rich history.

Comstock Announces Full Year 2023 Results

Retrieved on: 
Wednesday, February 28, 2024

VIRGINIA CITY, Nev., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced its full year 2023 results, 2023 summary achievements, and our 2024 business outlook.

Key Points: 
  • VIRGINIA CITY, Nev., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced its full year 2023 results, 2023 summary achievements, and our 2024 business outlook.
  • “I just toured our recycling facility, with all equipment in place and pre-commissioning activities well underway,” stated Mr. De Gasperis.
  • “Our 2023 achievements were foundational and established a shared corporate services platform that enables speed for each of our business teams,” stated Mr. De Gasperis.
  • On June 30, 2023, the Company signed a Mineral Exploration and Mining Lease Agreement (the “Mining Lease”) with Mackay Precious Metals Inc. (“Mackay").

Avanti Communications Signs Strategic Collaboration Agreement With Telesat as Part of New Multi-Orbit Strategy

Retrieved on: 
Wednesday, February 21, 2024

Avanti plans to incorporate Telesat’s Lightspeed™ services into its network to provide affordable, high quality broadband connectivity worldwide.

Key Points: 
  • Avanti plans to incorporate Telesat’s Lightspeed™ services into its network to provide affordable, high quality broadband connectivity worldwide.
  • Avanti is investing heavily in strategic partnerships and its managed services to meet customers’ requirements in an evolving industry where demand for capacity is growing.
  • Avanti’s first low-latency LEO constellation agreement will support the execution of Avanti’s new strategy, which is built on a “customer pull” vs. “technology push” model.
  • The collaboration will be optimised to serve the critical connectivity requirements of Avanti’s enterprise and government customers once the Telesat Lightspeed constellation is operational in 2027.

LEO Pharma Unveils Late-Breaking Data for Landmark DELTA 3 Open-Label Extension Trial at the 2024 AAD Annual Meeting

Retrieved on: 
Saturday, March 9, 2024

For DELTA 3, subjects who completed the 16-week treatment period in one of the parent trials DELTA 1 and DELTA 2 were treated with twice daily delgocitinib cream as needed to control their chronic hand eczema for 36 weeks.

Key Points: 
  • For DELTA 3, subjects who completed the 16-week treatment period in one of the parent trials DELTA 1 and DELTA 2 were treated with twice daily delgocitinib cream as needed to control their chronic hand eczema for 36 weeks.
  • “Having the opportunity to present the DELTA 3 findings for the first time at AAD is a chance to prove our complete dedication to addressing the immense burden of this disease.
  • By continuing to share our key data at major dermatology congresses, we hope to drive forward the clinical development of delgocitinib cream as a potential new treatment option.”
    Key secondary endpoints demonstrated an efficacy profile consistent with DELTA 1 and 2 parent trials.
  • Alongside the presentation, new data sets at AAD were shared as e-posters from the preceding DELTA 1 and 2 trials regarding safety, efficacy and systemic exposure.2,3,4

LEO Pharma Presents New Long-Term Adbry® (tralokinumab-ldrm) Data in Adults with Moderate-to-Severe Atopic Dermatitis at the 2024 AAD Annual Meeting

Retrieved on: 
Friday, March 8, 2024

LEO Pharma A/S, a global leader in medical dermatology, today unveiled new data analyzing the long-term therapeutic response of treatment with Adbry® (tralokinumab-ldrm) in adults (18 years and above) with moderate-to-severe atopic dermatitis (AD).

Key Points: 
  • LEO Pharma A/S, a global leader in medical dermatology, today unveiled new data analyzing the long-term therapeutic response of treatment with Adbry® (tralokinumab-ldrm) in adults (18 years and above) with moderate-to-severe atopic dermatitis (AD).
  • The findings are being shared via an e-poster at the 82nd American Academy of Dermatology (AAD) Congress in San Diego, California.1
    The results are part of a wide-ranging data program from LEO Pharma at AAD, with eight abstracts accepted in total for the meeting, showcasing an ongoing commitment to advancing the standard of research in medical dermatology.
  • “The data presented for Adbry at AAD further builds upon an established, wide-ranging collection of clinical evidence that aims to improve the support for those living with moderate-to-severe AD,” said Brian Hilberdink, EVP and President, Region North America, LEO Pharma.
  • “This new analysis demonstrates the benefits of the long-term use of Adbry for adults who live with this chronic condition.”

Maxar Space Systems selected by L3Harris Technologies to support Tranche 2 Tracking Layer Program

Retrieved on: 
Thursday, March 7, 2024

Maxar Space Systems, a leading provider of comprehensive space technologies, today announced it has been selected by L3Harris Technologies for the design and production of eighteen Maxar 300 spacecraft platforms and associated support for its Tranche 2 Tracking Layer program with the Space Development Agency (SDA).

Key Points: 
  • Maxar Space Systems, a leading provider of comprehensive space technologies, today announced it has been selected by L3Harris Technologies for the design and production of eighteen Maxar 300 spacecraft platforms and associated support for its Tranche 2 Tracking Layer program with the Space Development Agency (SDA).
  • This selection builds on Maxar Space Systems’ existing contract with L3Harris for the Tranche 1 Tracking Layer, awarded in 2022.
  • View the full release here: https://www.businesswire.com/news/home/20240307860226/en/
    Maxar Space Systems Tranche 2 Tracking Layer Rendering (Photo: Maxar Space Systems)
    The Tranche 2 Tracking Layer will enhance SDA’s capability to provide global, persistent indications, detection, warning, and tracking, of conventional and advanced missile threats, including hypersonic missile systems.
  • “Maxar Space Systems is excited to partner with L3Harris again on behalf of the Space Development Agency,” said Chris Johnson, CEO of Maxar Space Systems.

Viasat and Rocket Lab Partner to Showcase On-Demand, Low-Latency Data Relay Services for LEO Satellites

Retrieved on: 
Thursday, March 7, 2024

The demonstrations will make evident Viasat’s portfolio of multi-band, space-based relay communication services in support of Low Earth Orbit (LEO) space missions with substantial flexibility in managing data, with lower data latency and higher throughput in real time.

Key Points: 
  • The demonstrations will make evident Viasat’s portfolio of multi-band, space-based relay communication services in support of Low Earth Orbit (LEO) space missions with substantial flexibility in managing data, with lower data latency and higher throughput in real time.
  • LEO satellites typically require direct line-of-sight to a ground station to communicate, introducing significant data latency into the mission operations.
  • The Real-Time Space Relay (RTSR) space-qualified Ka-band terminal will use Viasat’s high-capacity Ka-band network of satellites in geostationary orbit (GEO) to enable LEO operators on-demand access to critical mission data.
  • Rocket Lab will also provide a new L-band radio for InCommand called Frontier, which will support demonstrations of various TT&C applications.

LEO Pharma to Maintain Leadership Role at AAD in 2024 with New Late-Breaking Data Spanning Multiple Therapeutic Areas

Retrieved on: 
Wednesday, March 6, 2024

LEO Pharma A/S, a global leader in medical dermatology, will present a breadth of new data on moderate-to-severe chronic hand eczema (CHE), congenital ichthyosis (CI) and atopic dermatitis (AD) at the upcoming 82nd American Academy of Dermatology (AAD) Annual Meeting.

Key Points: 
  • LEO Pharma A/S, a global leader in medical dermatology, will present a breadth of new data on moderate-to-severe chronic hand eczema (CHE), congenital ichthyosis (CI) and atopic dermatitis (AD) at the upcoming 82nd American Academy of Dermatology (AAD) Annual Meeting.
  • The event is being held from March 8th to 12th in San Diego, California.
  • “Our growing body of clinical evidence reinforces our passion and commitment to advancing the standard of care in medical dermatology,” said Kreesten Meldgaard Madsen, LEO Pharma’s Chief Development Officer.
  • I am proud that we can follow up on our 2023 AAD program with this level of critical data,” said Brian Hilberdink, EVP and President, Region North America, LEO Pharma.